Korean J Thorac Cardiovasc Surg.
2003 Mar;36(3):175-181.
Clinical Review of Primary Chest Wall Tumors
- Affiliations
-
- 1Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Korea. kychu@yumc.yonsei.ac.kr
Abstract
-
BACKGROUND: Primary chest wall tumors originate from soft tissue, bone or cartilage of the chest wall and it comprises 1~2% of all primary tumors. Resection of tumor is often indicated for chronic ulceration or pain, and long-term survival might be achieved after surgery depending on the histology and the surgical procedure.
MATERIAL AND METHOD: Retrospective study of 125 primary chest wall tumors (86 benign, 39 malignant) operated between Sep. 1976 to Mar. 2001 were reviewed and their clinical outcomes were analyzed. Follow-up data were collected at the outpatient clinic.
RESULT: All patients with benign tumors were treated by excision without recurrence or death, and most malignancies were treated by wide resection.
Malignant fibrous histiocytoma and chondrosarcoma constituted 46.2% of the malignant neoplasm. There was no operative death. The overall 3-year survival for patients with primary malignant neoplasm was 76.0%, and the 10-year survival was 60.5%. All deaths were disease-related and the tumor recurred in 11 patients. There was no significant difference in survival between patients with resection margins less than 4 cm and those with resection margins greater than 4 cm.
CONCLUSION
Chest wall resection offers excellent results for benign chest wall tumors and substantial long-term survival for malignant diseases. Safe resection margin of 4 cm or more did not correlate with the survival rate although the tumor recurrence correlated with poor survival.